<DOC>
	<DOCNO>NCT02541344</DOCNO>
	<brief_summary>In trial , investigational product , active ingredient proven reduce postprandial glucose healthy diabetic patient , test . The primary aim clinical study evaluate possibility investigational product reduce rise postprandial glucose AUC level overweight Caucasian subject normal prediabetic biomarkers ( IFG/HbA1C ) , without prompt disproportionate rise insulin level .</brief_summary>
	<brief_title>Benefit IQP-VV-102 Reducing Postprandial Glucose Level Overweight Caucasian Subjects</brief_title>
	<detailed_description />
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Prediabetic State</mesh_term>
	<criteria>Caucasian BMI ≥ 25 &lt; 30 kg/m2 Normal prediabetic biomarkers : FBG 3.96.9 mmol/L / 70125mg/dL HbA1c 46.4 % Willing take test meal adhere consumption preprepared meal supply ( control subject diary ) Willing maintain level physical activity study Willing arrive study site , nonstrenuous mean transportation study Negative pregnancy test ( beta hCG ) woman childbearing potential screen Women childbearing potential agree use appropriate birth control method study period Written inform consent subject participate prerequisite study participation Known sensitivity Larabinose grape marc extract , source active ingredient excipients Use medication dietary supplement may influence body weight 4 week , gastrointestinal function 2 week prior enrolment study Use antidiabetic medication Strenuous exercise within one day prior blood glucose sampling ( include screen ) . History bariatric surgery , small bowel resection , extensive bowel resection Difficult vein Recent blood donation last 1 month prior study Pregnancy nursing Clinically relevant excursion safety parameter Any serious condition disease render subject ineligible Smoking Exceeding safe alcohol consumption ( men : ≥ 21 units/week ; woman : ≥ 14 units/week ) alcohol consumption within 24 hour venous blood glucose sample All vegetarian subject selfreported diet high fat protein Subjects able communicate local study staff Recent antibiotic cortisone use one week study Participation another study last 30 day screen visit ( V1 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>